Literature DB >> 30632021

Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis.

Ramy Gadalla1,2, Hebatallah Hassan3, Sherif Abdelaziz Ibrahim3, Mahmoud Salah Abdullah3, Ahmed Gaballah4, Burkhard Greve5, Somaya El-Deeb3, Mohamed El-Shinawi6, Mona Mostafa Mohamed3.   

Abstract

PURPOSE: Plasmacytoid dendritic cells (PDCs) infiltration into breast cancer tissues is associated with poor prognosis. Also, CXCR4 shows compelling evidences to be exploited by cancer cells to migrate to distant sites. The present study investigated lymph node metastasis in the light of PDCs infiltration and the potential cross talk with CXCR4/SDF-1 chemokine axis.
METHODS: We assessed circulating PDCs proportions drained from the axillary tributaries, and the in situ expression of both CD303 and CXCR4 in breast cancer patients with positive lymph nodes (pLN) and negative lymph nodes (nLN) using immunohistochemistry and flow cytometry. We also analyzed the expression of SDF-1 in lymph nodes of pLN and nLN patients. We studied the effect of the secretome of PDCs of pLN and nLN patients on the expression of CXCR4 and activation of NF-κB in human breast cancer cell lines SKBR3 and MCF-7. TNF-α mRNA expression level in PDCs from both groups was determined by qPCR.
RESULTS: Our findings indicate increased infiltration of PDCs in breast cancer tissues of pLN patients than nLN patients, which correlates with CXCR4+ cells percentage. Interestingly, SDF-1 is highly immunostained in lymph nodes of pLN patients compared to nLN patients. Our in vitro experiments demonstrate an upregulation of NF-κB expression and CXCR4 cells upon stimulation with PDCs secretome of pLN patients than those of nLN patients. Also, PDCs isolated from pLN patients exhibited a higher TNF-α mRNA expression than nLN patients. Treatment of MCF-7 cell lines with TNF-α significantly upregulates CXCR4 expression.
CONCLUSIONS: Our findings suggest a potential role for microenvironmental PDCs in breast cancer lymph node metastasis via CXCR4/SDF-1 axis.

Entities:  

Keywords:  Breast cancer; CXCR4; Lymph node metastasis; Plasmacytoid dendritic cells

Mesh:

Substances:

Year:  2019        PMID: 30632021     DOI: 10.1007/s10549-019-05129-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

Review 1.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 2.  Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma.

Authors:  Matilde Monti; Francesca Consoli; Raffaella Vescovi; Mattia Bugatti; William Vermi
Journal:  Cells       Date:  2020-02-11       Impact factor: 6.600

3.  Increased tumor-infiltrating plasmacytoid dendritic cells promote cancer cell proliferation and invasion via TNF-α/NF-κB/CXCR-4 pathway in oral squamous cell carcinoma.

Authors:  Nannan Han; Xing Li; Yupu Wang; Lin Wang; Chunye Zhang; Zun Zhang; Min Ruan; Chenping Zhang
Journal:  J Cancer       Date:  2021-03-19       Impact factor: 4.207

4.  A Comprehensive Investigation to Reveal the Relationship Between Plasmacytoid Dendritic Cells and Breast Cancer by Multiomics Data Analysis.

Authors:  Saisai Tian; Li Yan; Lu Fu; Zhen Zhang; Jinbo Zhang; Guofeng Meng; Weidong Zhang
Journal:  Front Cell Dev Biol       Date:  2021-04-01

5.  Dendritic Cells Are Associated with Prognosis and Survival in Breast Cancer.

Authors:  Joanna Szpor; Joanna Streb; Anna Glajcar; Paulina Frączek; Aleksandra Winiarska; Katarzyna E Tyrak; Paweł Basta; Krzysztof Okoń; Robert Jach; Diana Hodorowicz-Zaniewska
Journal:  Diagnostics (Basel)       Date:  2021-04-14

6.  Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment.

Authors:  Zhulin Wu; Yingzhao Zhang; Xiang Chen; Wanjun Tan; Li He; Lisheng Peng
Journal:  Front Mol Biosci       Date:  2020-11-25

Review 7.  At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.

Authors:  Gary D Luker; Jinming Yang; Ann Richmond; Stefania Scala; Claudio Festuccia; Margret Schottelius; Hans-Jürgen Wester; Johann Zimmermann
Journal:  J Leukoc Biol       Date:  2020-10-26       Impact factor: 4.962

Review 8.  Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.

Authors:  Jarupa Soongsathitanon; Pranisa Jamjuntra; Nuttavut Sumransub; Supaporn Yangngam; Marjorie De la Fuente; Glauben Landskron; Peti Thuwajit; Marcela A Hermoso; Chanitra Thuwajit
Journal:  J Immunol Res       Date:  2021-07-13       Impact factor: 4.818

Review 9.  Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications.

Authors:  Annalisa Del Prete; Francesca Sozio; Ilaria Barbazza; Valentina Salvi; Laura Tiberio; Mattia Laffranchi; Angela Gismondi; Daniela Bosisio; Tiziana Schioppa; Silvano Sozzani
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

10.  Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.

Authors:  Crescenzo D'Alterio; Maria Buoncervello; Caterina Ieranò; Maria Napolitano; Luigi Portella; Giuseppina Rea; Antonio Barbieri; Antonio Luciano; Giosuè Scognamiglio; Fabiana Tatangelo; Anna Maria Anniciello; Mario Monaco; Ernesta Cavalcanti; Piera Maiolino; Giulia Romagnoli; Claudio Arra; Gerardo Botti; Lucia Gabriele; Stefania Scala
Journal:  J Exp Clin Cancer Res       Date:  2019-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.